Harmony Biosciences Holdings, Inc. (HRMY)
31.83
+0.57
(+1.82%)
USD |
NASDAQ |
May 01, 16:00
31.83
0.00 (0.00%)
After-Hours: 20:00
Harmony Biosciences Holdings Market Cap : 1.841B for May 1, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Castle Biosciences, Inc. | 751.64M |
| BioMarin Pharmaceutical, Inc. | 10.40B |
| Amicus Therapeutics, Inc. | 4.550B |
| Iovance Biotherapeutics, Inc. | 1.401B |
| Apellis Pharmaceuticals, Inc. | 5.236B |
Market Cap Related Metrics
| PE Ratio | 11.75 |
| PS Ratio | 2.148 |
| PEG Ratio | 1.485 |
| Price to Book Value | 2.116 |
| Price to Free Cash Flow | 5.675 |
| Price | 31.83 |
| Earnings Yield | 8.51% |
| PEGY Ratio | 1.485 |
| Operating PE Ratio | 8.946 |
| Normalized PE Ratio | 11.75 |